Table 1.
Methadone and Buprenorphine Provider Characteristics, Arizona 2022 (N=74)
| Characteristics | n (%) |
|---|---|
| Settings | |
| OUD treatment settings | |
| Stand-alone methadone clinic | 15 (20.3%) |
| SUD clinic (excluding stand-alone methadone clinics) | 14 (18.9%) |
| Other healthcare settings (non-OUD specific) | |
| Private medical office | 16 (21.6%) |
| Other (VA clinics, CHCs, correctional clinics, hospitals) | 29 (39.2%) |
| Medication type | |
| Methadone | 1 (1.4%) |
| Buprenorphine (alone or in combination with other nonmethadone treatment) | 48 (64.9%) |
| Methadone and buprenorphine | 25 (33.8%) |
| Provider type (completing the survey) | |
| Physician | 27 (36.5%) |
| Physician assistant | 4 (5.4%) |
| Nurse practitioner | 43 (58.1%) |
| DEA waiver patient prescribing limits | |
| 30 patients | 37 (50.0%) |
| 100 patients | 24 (32.4%) |
| 275 patients | 13 (17.6%) |
| Rurality | |
| Urban | 59 (80.0%) |
| Large and small rural city/town | 15 (20.0%) |
CHC, community health center; DEA, Drug Enforcement Administration; OUD, opioid use disorder; SUD, substance use disorder; VA, Veterans Affairs.